Skip to main content

Table 2 Frequency, age specific incidence rates, average annual crude incidence rates and ASR by site in males in Kumasi, 2015

From: Malignant tumours in urban Ghana: evidence from the city of Kumasi

Site /Age Group

All ages

Age Unknown

0–4

5–9

10–14

15–19

20–24

25–29

30–34

35–39

40–44

45–49

50–54

55–59

60–64

65–69

70–74

75+

Crude Rate

%

Cum (0–74)

ASR

ICD (10th)

Tongue

1

0

4.8

0.1

0.4

0.02

0.2

C01–02

Mouth

4

0

1.9

2.4

7.5

5.3

0.4

1.5

0.06

0.5

C03–06

Salivary glands

1

0

7.5

0.1

0.4

0.04

0.2

C07–08

Other oropharynx

3

0

4.1

4.8

7.5

0.3

1.1

0.08

0.5

C10

Nasopharynx

4

0

0.8

1.2

1.4

1.9

0.4

1.5

0.03

0.4

C11

Oesophagus

2

0

1.9

2.4

0.2

0.7

0.02

0.3

C15

Stomach

10

0

1.6

2.7

12.3

4.8

24.7

5.3

0.9

3.7

0.23

1.8

C16

Colon

3

0

1.6

2.7

4.8

8.2

0.3

1.1

0.07

0.5

C18

Rectum

6

0

2.7

1.6

1.9

2.7

4.1

0.5

2.2

0.07

0.7

C19–20

Anus

2

0

0.2

0.7

0.03

0.3

C21

Liver

58

0

0.6

1.2

6.9

17.8

15.1

14.3

27.4

32.9

4.8

32.9

7.5

5.2

21

0.82

7.6

C22

Gallbladder etc.

1

0

8.2

0.1

0.4

0.04

0.2

C23–24

Pancreas

7

0

1.9

4.8

8.2

21.3

0.6

2.6

0.07

1

C25

Nose, sinuses etc.

3

0

2.7

2.7

0.3

1.1

0.03

0.3

C30–31

Larynx

3

0

4.8

7.5

0.3

1.1

0.07

0.4

C32

Trachea, bronchus and lung

5

0

5.5

4.1

8.2

7.5

0.5

1.8

0.13

0.8

C33–34

Other thoracic organs

2

0

4.1

7.5

0.2

0.7

0.06

0.3

C37–38

Bone

3

0

0.7

1.2

2.4

0.3

1.1

0.02

0.3

C40–41

Other skin

6

0

1.0

1.4

1.6

1.9

0.5

2.2

0.07

0.7

C44

Kaposi sarcoma

2

0

2.4

2.7

0.2

0.7

0.03

0.3

C46

Connective and soft tissue

11

0

0.6

2.2

1.0

1.2

3.2

4.8

2.7

1

4.1

0.08

1.1

C47,C49

Breast

7

0

1.0

3.8

4.1

0.6

2.6

0.04

0.8

C50

Prostate

67

0

1.4

2.4

2.7

16.5

57.2

107.0

52.8

138.5

6

24

1.22

10.5

C61

Testis

1

0

1.9

0.1

0.4

0.01

0.1

C62

Kidney

1

0

8.2

0.1

0.4

0.04

0.2

C64

Bladder

5

0

1.4

1.9

15.1

5.3

0.5

1.8

0.09

0.6

C67

Eye

4

0

2.5

0.4

1.5

0.01

0.3

C69

Brain, nervous system

1

0

2.4

0.1

0.4

0.01

0.1

C70–72

Thyroid

1

0

7.5

0.1

0.4

0.04

0.2

C73

Adrenal gland

2

0

0.6

7.5

0.2

0.7

0.04

0.2

C74

Hodgkin disease

2

0

1.0

2.7

0.2

0.7

0.02

0.2

C81

Non-Hodgkin lymphoma

25

0

1.9

2.7

1.5

0.8

1.0

3.5

1.4

1.6

3.8

2.4

2.7

8.2

4.8

 

7.5

5.3

2.3

9.2

0.22

2.5

C82–85,C96

Lymphoid leukaemia

3

0

7.5

0.3

1.1

0.04

0.3

C91

Myeloid leukaemia

4

0

0.8

3.8

0.4

1.5

0.03

0.4

C92–94

Other and unspecified

17

0

0.7

3.0

1.2

3.2

5.7

9.5

2.7

12.3

4.8

1.7

7

0.22

2.3

O&U

All sites

277

0

7.5

2.7

5.9

2.5

7.9

9.3

19.2

34.0

47.2

47.7

60.4

111.1

100.1

205.8

150.9

197.1

25.1

100

4.09

37.1

ALL

All sites but C44

271

0

7.5

2.7

5.9

2.5

7.9

9.3

19.2

34.0

47.2

47.7

60.4

102.9

100.1

205.8

150.9

197.1

24.5

4.02

36.4

ALLbC44